Who
Christopher M. Smith
Director
Company insider
Files Form 4 as: Director, Pacific Biosciences of California; Chief Executive Officer, NeoGenomics; Director, QuidelOrtho; Director, Akouos; Chairman and CEO, Ortho Clinical Diagnostics Holdings; Director, Universal Biosensors; Director, Startek; Director, Xtent.
In numbers
- Trades disclosed
- 52
- Buys
- 1
- Sells
- 4
- Bought
- $337.5M
- Sold
- $8.0M
- Companies
- 8
- Companies where not an officer
- 6
- First trade
- 18 Jun 2008
- Last trade
- 3 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 4 Jun 2026 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —223,492 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —223,492 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —32,500 at $0.00 | filing |
| 23 Feb 2025filed 25 Feb 2025 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code M | —57,413 at $0.00 | filing |
| 23 Feb 2025filed 25 Feb 2025 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code M | —57,413 at $0.00 | filing |
| 23 Feb 2025filed 25 Feb 2025 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code F | —14,067 at $0.00 | filing |
| 30 Jan 2025filed 3 Feb 2025 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —72,901 at $0.00 | filing |
| 30 Jan 2025filed 3 Feb 2025 | PACB Pacific Biosciences of CaliforniaLife-science tools | SEC FORM 4 Code A | —54,099 at $0.00 | filing |
| 15 Aug 2024filed 19 Aug 2024 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code F | —33,130 at $0.00 | filing |
| 11 May 2024filed 4 Dec 2024 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code M | —48,063 at $0.00 | filing |
| 11 May 2024filed 4 Dec 2024 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code M | —48,063 at $0.00 | filing |
| 11 May 2024filed 4 Dec 2024 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code F | $281K18,913 at $14.86 | filing |
| 11 May 2024filed 14 May 2024 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code M | —48,063 at $0.00 | filing |
| 11 May 2024filed 14 May 2024 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code M | —48,063 at $0.00 | filing |
| 11 May 2024filed 14 May 2024 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code F | $281K18,913 at $14.86 | filing |
| 11 May 2024filed 14 May 2024 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code M | —48,063 at $0.00 | filing |
| 23 Feb 2024filed 27 Feb 2024 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —287,940 at $0.00 | filing |
| 23 Feb 2024filed 27 Feb 2024 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —172,239 at $0.00 | filing |
| 23 Feb 2024filed 27 Feb 2024 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —172,240 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,248 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.